Synapse - Tiffany Traina

Results (250)

Cognitive effects of cancer and its treatments at the intersection of aging: What do we know; What do we need to know?

Journal Article

Mandelblatt, J. S.; Hurria, A.; McDonald, B. C.; Saykin, A. J.; Stern, R. A.; Vanmeter, J. W.; McGuckin, M.; Traina, T.; Denduluri, N.; Turner, S.; more...
Seminars in Oncology (2013)

Fulltext@MSK | Save

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer

Journal Article

Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save

Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer

Journal Article

Zumsteg, Z. S.; Morrow, M.; Arnold, B.; Zheng, J.; Zhang, Z.; Robson, M.; Traina, T.; McCormick, B.; Powell, S.; Ho, A. Y.
Annals of Surgical Oncology (2013)

Fulltext@MSK | Save

Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy

Journal Article

Cadoo, K. A.; Traina, T. A.; King, T. A.
Surgical Oncology Clinics of North America (2013)

Fulltext@MSK | Save

The role of the androgen receptor in triple-negative breast cancer

Journal Article

Shah, P. D.; Gucalp, A.; Traina, T. A.
Women's Health (2013)

Fulltext@MSK | Save

Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: A large, single-institution retrospective analysis

Journal Article

Perez, C. A.; Zumsteg, Z. S.; Gupta, G.; Morrow, M.; Arnold, B.; Patil, S. M.; Traina, T. A.; Robson, M. E.; Wen, Y. H.; McCormick, B.; more...
Breast Cancer Research and Treatment (2013)

Fulltext@MSK | Save

Rehabilitation of cognitive changes in breast cancer survivors

Meeting Abstract

Haynes, S.; Ryan, E.; Wood, H.; Fallon, J.; Cook, E.; Bolutayo, K.; Li, Y. L.; Hudis, C.; Traina, T.; Ahles, T.
Psycho-Oncology (2013)

Fulltext@MSK | Save

IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer

Meeting Abstract

Traina, T. A.; Hudis, C.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; Norton, L.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)